[go: up one dir, main page]

Tabbara et al., 2023 - Google Patents

Current approaches in surgical and immunotherapy-based management of renal cell carcinoma with tumor thrombus

Tabbara et al., 2023

View HTML
Document ID
1646677617512392473
Author
Tabbara M
González J
Martucci M
Ciancio G
Publication year
Publication venue
Biomedicines

External Links

Snippet

Renal cell carcinoma (RCC) accounts for 2–3% of all malignant disease in adults, with 30% of RCC diagnosed at locally advanced or metastatic stages of disease. A form of locally advanced disease is the tumor thrombus (TT), which commonly grows from the intrarenal …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups

Similar Documents

Publication Publication Date Title
de Scordilli et al. Targeted therapy and immunotherapy in early-stage non-small cell lung cancer: current evidence and ongoing trials
Angerilli et al. The role of the pathologist in the next-generation era of tumor molecular characterization
Lawlor et al. Prognostic role of high-grade tumor budding in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis with a focus on epithelial to mesenchymal transition
Tabbara et al. Current approaches in surgical and immunotherapy-based management of renal cell carcinoma with tumor thrombus
Hayasaki et al. Survival analysis in patients with pancreatic ductal adenocarcinoma undergoing chemoradiotherapy followed by surgery according to the international consensus on the 2017 definition of borderline resectable cancer
Słodkowski et al. Current approaches for the curative-intent surgical treatment of pancreatic ductal adenocarcinoma
Sommariva et al. Colorectal cancer with peritoneal metastases: the impact of the results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 trials on peritoneal disease management
Rizzo et al. Adjuvant PD-1 and PD-L1 inhibitors and relapse-free survival in cancer patients: the MOUSEION-04 study
Kolawa et al. Overview, diagnosis, and perioperative systemic therapy of upper tract urothelial carcinoma
Mantziari et al. A comprehensive review of prognostic factors in patients with gastric adenocarcinoma
Usai et al. Zebrafish patient-derived xenografts identify chemo-response in pancreatic ductal adenocarcinoma patients
Ruggeri et al. HER2 analysis in sporadic thyroid cancer of follicular cell origin
Caban et al. Gaps and opportunities in the diagnosis and treatment of pancreatic cancer
Keegan et al. Phase Ib trial of copanlisib, a phosphoinositide-3 kinase (PI3K) inhibitor, with trastuzumab in advanced pre-treated HER2-positive breast cancer “PantHER”
Tinterri et al. Loco-regional treatment of the primary tumor in de novo metastatic breast cancer patients undergoing front-line chemotherapy
Lee et al. Savolitinib: a promising targeting agent for cancer
De Simoni et al. Could total neoadjuvant therapy followed by surgical resection be the new standard of care in pancreatic cancer? A systematic review and meta-analysis
Liang et al. From conversion to resection for unresectable hepatocellular carcinoma: A review of the latest strategies
Matschos et al. The HROC-Xenobank—A high quality assured PDX biobank of> 100 individual colorectal cancer models
Hasselluhn et al. Stromal features of the primary tumor are not prognostic in genetically engineered mice of pancreatic cancer
Bui et al. PSMA-expression is highly associated with histological subtypes of renal cell carcinoma: potential implications for theranostic approaches
Gasparro et al. High prognostic value of 68Ga-PSMA PET/CT in renal cell carcinoma and association with PSMA expression assessed by immunohistochemistry
Díaz Casas et al. Prognostic factors associated with tumor recurrence and overall survival in soft tissue sarcomas of the extremities in a Colombian reference cancer center
Anselmo et al. Primary versus salvage liver transplantation after curative-intent resection or radiofrequency ablation for hepatocellular carcinoma: long-term oncological outcomes
Tiberio et al. Hyperthermic intraperitoneal chemotherapy for primary or recurrent adrenocortical carcinoma. A single center study